FY2026 · ended Jun 30, 2026 · Revenue $0, -100.0% YoY · Filed Sep 25, 2026
Incannex Healthcare Inc. (IXHL) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2026, which ended Jun 30, 2026, it reported revenue of $0 and a net loss of $19.3 million. Free cash flow was -$12.9 million. As of Jun 30, 2026 it held $67.7 million in cash and investments and $96,000 in total debt.
Revenue
$0
-100.0% vs prior year
Net income
$-19.30M
+58.8% vs prior year
Operating cash flow
$-12.87M
-2.8% vs prior year
Free cash flow
$-12.88M
-2.8% vs prior year
EPS
$-1.66
+95.9% vs prior year
Dividend per share
None
Shares outstanding
12.54M
-96.4% vs prior year
Net cash
$67.61M
FY 2026
Operating margin
-27661.6%
FY 2025
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IXHL (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Norwest Nsw
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1873875
- Former names
- Incannex Healthcare Ltd (until Nov 29, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Jun 30, 2026 |
FY 2025 Jun 30, 2025 |
FY 2024 Jun 30, 2024 |
FY 2023 Jun 30, 2021 |
|---|---|---|---|---|
| Revenue | $0 | $86,000 | $12,000 | $1.9M |
| Operating income | -$23.0M | -$23.8M | -$30.0M | — |
| Net income | -$19.3M | -$46.9M | -$18.5M | — |
| Diluted EPS | -$1.66 | -$40.82 | -$1.15 | — |
| Operating cash flow | -$12.9M | -$12.5M | -$15.8M | — |
| Free cash flow | -$12.9M | -$12.5M | -$16.1M | — |
| Total assets | $73.0M | $20.4M | $17.0M | — |
| Total liabilities | $5.6M | $7.1M | $5.8M | — |
| Stockholders' equity | $67.4M | $13.4M | $11.2M | — |
| Cash and investments | $67.7M | $15.0M | $5.9M | — |
| Total debt | $96,000 | $258,000 | $372,000 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Oct 28, 2026 | Jun 30, 2026 |
| 10-K | Annual report | Sep 25, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 25, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 23, 2026 | Jul 23, 2026 |
All 266 Incannex Healthcare Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.